OMX Nordic 40
2.435,58
PKT
+16,77
PKT
+0,69
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.11.20 | A.P. Moeller - Maersk A-S (B) kaufen | Goldman Sachs Group Inc. | |
| 20.11.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 20.11.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 20.11.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 20.11.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 20.11.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 19.11.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 19.11.20 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.20 | A.P. Moeller - Maersk A-S (B) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.11.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 19.11.20 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 19.11.20 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 18.11.20 | Kone overweight | JP Morgan Chase & Co. | |
| 18.11.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 18.11.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 16.11.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 13.11.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 10.11.20 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 10.11.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.11.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.20 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 09.11.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.11.20 | Novo Nordisk Neutral | UBS AG | |
| 09.11.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 09.11.20 | Novo Nordisk Underweight | Morgan Stanley | |
| 06.11.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.20 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Volvo (B) buy | Jefferies & Company Inc. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.11.20 | AstraZeneca Sell | UBS AG | |
| 05.11.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.11.20 | AstraZeneca Hold | Jefferies & Company Inc. |